Related content

A prospective case series of women with estrogen receptor-positive breast cancer: levels of tamoxifen metabolites in controlled ovarian stimulation with high-dose tamoxifen

By Balkenende E.M.E.   Dahhan T.   Linn S.C.   Jager N.G.L.   Beijnen J.H.   Goddijn M.  

Human Reproduction, Vol. 28, Iss. 4, 2013-04 ,pp. : 953-959

Oxford University Press

Access to resources Recommend Favorite

Estrogen receptor polymorphisms in tamoxifen-treated women with breast cancer

By Georgopoulos Neoklis   Adonakis George   Fotopoulos Andreas   Koika Vasiliki   Spinos Nikitas   Saltamavros Alexandros   Keramopoulos Antonios   Koukouras Dimitrios   Decavalas George   Kourounis George  

Gynecological Endocrinology, Vol. 22, Iss. 4, 2006-04 ,pp. : 185-189

Informa Healthcare

Access to resources Recommend Favorite

Vaginal atrophy in breast cancer survivors: role of vaginal estrogen therapy

By Mariani Luciano   Gadducci Angiolo   Vizza Enrico   Tomao Silverio   Vici Patrizia  

Gynecological Endocrinology, Vol. 29, Iss. 1, 2013-01 ,pp. : 25-29

Informa Healthcare

Access to resources Recommend Favorite

Hormone Replacement Therapy in Women with Previous Breast Cancer

By Marsden J.   Baum M.   Sacks N.P.M.  

Trends in Endocrinology and Metabolism, Vol. 9, Iss. 1, 1998-01 ,pp. : 32-38

Elsevier

Access to resources Recommend Favorite

Hormone replacement therapy in women with a history of breast cancer

By Ylikorkala O.   Metsä-Heikkilä M.  

Gynecological Endocrinology, Vol. 16, Iss. 6, 2002-12 ,pp. : 469-478

Informa Healthcare

Access to resources Recommend Favorite